Showing results (51-60 of 452) with videos related to
Sort By:
Pageof 46
The New Zealand Medical Journal|October 26, 1977
The use of triacetyloleandomycin in skin and soft tissue infections: results of a New Zealand general-practitioner multi-centre trialG P Vaughan, A M VaughanJournal of Pharmaceutical Sciences|April 1, 1976
Simple transformation method for predicting plasma drug profiles from dissolution ratesD P Vaughan, R H LeachNature Communications|April 28, 2019
Water quality improvements offset the climatic debt for stream macroinvertebrates over twenty yearsIan P Vaughan, Nicholas J GotelliBulletin of the World Health Organization|January 1, 1979
A comparison of cardiovascular measurements in the Gambia, Jamaica, and the United Republic of TanzaniaJ P Vaughan, W E MiallEuropean Journal of Clinical Pharmacology|January 1, 1976
General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapyD P Vaughan, G T TuckerCancer Research|May 1, 1983
Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat modelW P Vaughan, P J BurkeMutation Research|March 1, 1993
Induction of the adaptive response of Escherichia coli to alkylation damage by the environmental mutagen, methyl chlorideP Vaughan, T Lindahl, B SedgwickSleep Medicine Clinics|February 8, 2018
Sleep and Nocturia in Older AdultsCamille P Vaughan, Donald L BliwiseAmerican Journal of Medical Genetics. Part A|December 21, 2021
Extending the phenotype of posterior column ataxia with retinitis pigmentosa caused by variants in FLVCR1David P Vaughan, Daniel J CostelloPageof 46